Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus
about
Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*)Toll-like receptor 9-dependent immune activation by unmethylated CpG motifs in Aspergillus fumigatus DNASpatiotemporal Regulation of Hsp90-Ligand Complex Leads to Immune ActivationTargeted therapeutics in SLE: emerging strategies to modulate the interferon pathwayNeutrophil extracellular traps (Nets) impact upon autoimmune disordersInflammatory cytokines in systemic lupus erythematosusToll-like receptors in systemic lupus erythematosus: potential targets for therapeutic interventionReview of experimental animal models of biliary acute pancreatitis and recent advances in basic researchThe TLR and IL-1 signalling network at a glanceThe enemy within: endogenous retroelements and autoimmune diseaseNucleic acids and endosomal pattern recognition: how to tell friend from foe?Blocking TLR7- and TLR9-mediated IFN-α production by plasmacytoid dendritic cells does not diminish immune activation in early SIV infectionSequences derived from self-RNA containing certain natural modifications act as suppressors of RNA-mediated inflammatory immune responsesCell Type-Specific Recognition of Human Metapneumoviruses (HMPVs) by Retinoic Acid-Inducible Gene I (RIG-I) and TLR7 and Viral Interference of RIG-I Ligand Recognition by HMPV-B1 PhosphoproteinStructural reorganization of the Toll-like receptor 8 dimer induced by agonistic ligandsToll-like receptor 8 senses degradation products of single-stranded RNAToll-like receptors in the pathogenesis of autoimmune diseases: recent and emerging translational developmentsPathogenic Inflammation and Its Therapeutic Targeting in Systemic Lupus ErythematosusHCV RNA Activates APCs via TLR7/TLR8 While Virus Selectively Stimulates Macrophages Without Inducing Antiviral ResponsesTLR8 deficiency leads to autoimmunity in miceThe dendritic cell response to classic, emerging, and homeostatic danger signals. Implications for autoimmunityNucleic acid scavenging polymers inhibit extracellular DNA-mediated innate immune activation without inhibiting anti-viral responsesGuanine-modified inhibitory oligonucleotides efficiently impair TLR7- and TLR9-mediated immune responses of human immune cellsCancer immunotherapy via dendritic cellsRecent insights into the implications of metabolism in plasmacytoid dendritic cell innate functions: Potential ways to control these functionsCD2 distinguishes two subsets of human plasmacytoid dendritic cells with distinct phenotype and functions.Functional interaction of plasmacytoid dendritic cells with multiple myeloma cells: a therapeutic target.Phagosomal signaling by Borrelia burgdorferi in human monocytes involves Toll-like receptor (TLR) 2 and TLR8 cooperativity and TLR8-mediated induction of IFN-betaAntiviral defense: interferons and beyondInnate Invariant NKT Cell Recognition of HIV-1-Infected Dendritic Cells Is an Early Detection Mechanism Targeted by Viral Immune Evasion.Plasmacytoid dendritic cells, interferon signaling, and FcγR contribute to pathogenesis and therapeutic response in childhood immune thrombocytopenia.Ribosomal and immune transcripts associate with relapse in acquired ADAMTS13-deficient thrombotic thrombocytopenic purpuraViraemia, immunogenicity, and survival outcomes of cytomegalovirus chimeric epitope vaccine supplemented with PF03512676 (CMVPepVax) in allogeneic haemopoietic stem-cell transplantation: randomised phase 1b trialNanoparticle-delivered multimeric soluble CD40L DNA combined with Toll-Like Receptor agonists as a treatment for melanoma.Borrelia burgdorferi RNA induces type I and III interferons via Toll-like receptor 7 and contributes to production of NF-κB-dependent cytokinesImmunotherapy of Dual-Function Vector with Both Immunostimulatory and B-Cell Lymphoma 2 (Bcl-2)-Silencing Effects on Gastric Carcinoma.Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1.Interferon-alpha: a therapeutic target in systemic lupus erythematosusEvolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation.A genomic approach to human autoimmune diseases.
P2860
Q24631660-9E1C9BED-D739-4EF0-9CCC-B230837E9C8EQ24656078-9512B3A0-F791-4541-AA21-106194B4D679Q26744078-D809C4E9-A480-42C2-A7F0-E0C59B884EF2Q26746697-9A38A8EB-CFB0-482F-B5DC-A6F306F5CDF5Q26777984-6830EEA4-11D4-4205-988B-940875C616C8Q26823647-53EC57EB-B266-4052-BF22-81FB95DF0DCCQ26865485-D200C661-F803-492E-8C5E-01D801E07EEFQ27001120-4B4D1E54-7C83-415D-B8DF-5FAC5DDF8B92Q27013358-216B649A-8989-47C0-8B2F-0F79E4C3655CQ27021785-F98B9A79-6716-4AD9-86D3-758BF463DBC4Q27022525-6E61C361-BFBC-419A-9200-7F6812926AA2Q27334176-374D3D5E-5473-4CBE-AEE1-442CF57D0797Q27489416-14E118DA-8414-47A7-AB1A-93617EC047D5Q27491027-AA5390E4-525F-4B0A-9291-879CEF7F21B9Q27684259-5B3CC21E-542F-4385-8F7E-744574821931Q27697581-D08741F8-A98E-4CB2-8CF1-10D2665991C3Q28067211-76B9F5C5-D6CA-445D-AB1C-4077514B6397Q28088753-7184F607-ABCF-435A-A4D3-42396241F0ECQ28276935-CEAC784B-A30E-4CAB-BB7B-624D01CE7E97Q28292240-A5424350-8923-459B-9939-1EC6CEF59A38Q28384138-70979FE0-DF84-4DF1-9A38-6E8F3054B499Q28534779-C95DB6DC-7D4A-4106-A9AC-79E544F00804Q28543539-C06431B7-CD01-4FD5-8D0F-896E3CADF338Q29615444-7059B37B-2497-47B9-8E8E-3739D2578B36Q30252210-8DFD08C2-CE03-4DDC-8F6A-B6309E8F631AQ30490447-DB89BF8B-76F7-42D0-AA8B-67BE6D76AC45Q30490975-008E8402-FE71-4CED-B3CB-63EF740363C9Q30498311-DE6B5FE6-C32E-4A9E-8384-6C6102F81C51Q33252389-AE303A59-64F7-4CAD-AF9E-959CDC4A9A88Q33390790-3ABB0149-3E1E-4563-8F1D-CEB63A665FF7Q33409032-13A6F1A5-058B-4FBD-BACD-7BE66D9834D5Q33420289-3AACB45A-A92C-48C5-A58F-DC1B5EAA45F9Q33429827-E719EB36-0BB5-4576-B2C4-9302FEDD13ACQ33509292-0F1F4E5B-003F-4DDA-BB4D-9566D66013B7Q33603081-672C6285-2A14-4357-96E8-0DEE0932B616Q33626347-00807107-1A00-4D7A-B74C-C0999BB58FD3Q33649753-85E1AD61-990D-4084-AD66-D5F406327D00Q33744320-277BFB54-8FB9-433E-BBDF-08470B6B4445Q33755829-E7610B1E-9F7D-4FFD-B635-B9ABE9781EC2Q33762839-E507C0A9-F4C3-483D-8460-26EB74A366BC
P2860
Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Nucleic acids of mammalian ori ...... e systemic lupus erythematosus
@ast
Nucleic acids of mammalian ori ...... e systemic lupus erythematosus
@en
type
label
Nucleic acids of mammalian ori ...... e systemic lupus erythematosus
@ast
Nucleic acids of mammalian ori ...... e systemic lupus erythematosus
@en
prefLabel
Nucleic acids of mammalian ori ...... e systemic lupus erythematosus
@ast
Nucleic acids of mammalian ori ...... e systemic lupus erythematosus
@en
P2093
P2860
P356
P1476
Nucleic acids of mammalian ori ...... e systemic lupus erythematosus
@en
P2093
Bonnie Chang
Franck J Barrat
Jean H Chan
Josh Gregorio
Omar Duramad
Robert L Coffman
Satoshi Uematsu
Thea Meeker
P2860
P304
P356
10.1084/JEM.20050914
P407
P50
P577
2005-10-01T00:00:00Z